XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Assumptions of Grant Date Fair Value of Stock Options Granted

The assumptions that the Company used in the Black-Scholes option-pricing model to determine the grant date fair value of stock options granted were as follows:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2023

 

2022

 

2023

 

2022

Risk-free interest rate range

 

3.96% - 4.62%

 

2.94%

 

3.40% - 4.62%

 

2.69% - 3.16%

Dividend yield

 

0.00%

 

0.00%

 

0.00%

 

0.00%

Expected life of options (years)

 

6.1

 

6.0 - 6.1

 

5.8-6.1

 

5.9 - 6.1

Volatility rate range

 

81.63% - 82.93%

 

82.49% - 82.54%

 

81.63% - 83.55%

 

71.06% - 82.54%

Fair value of common stock range

 

$8.95 - $12.37

 

$4.07

 

$8.95 - $20.50

 

$3.63 - $4.07

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity:

 

Number of
Shares

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Term
(in years)

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding as of December 31, 2022

 

 

3,300,935

 

 

$

6.29

 

 

 

9.26

 

 

$

18,346

 

Granted

 

 

236,393

 

 

$

12.11

 

 

 

 

 

 

 

Exercised

 

 

(183,927

)

 

$

2.49

 

 

 

 

 

 

 

Forfeited or canceled

 

 

(156,436

)

 

$

5.53

 

 

 

 

 

 

 

Outstanding as of September 30, 2023

 

 

3,196,965

 

 

$

6.97

 

 

 

8.32

 

 

$

12,146

 

Vested and expected to vest as of September 30, 2023

 

 

3,196,965

 

 

$

6.97

 

 

 

8.32

 

 

$

12,146

 

Vested and exercisable as of September 30, 2023

 

 

1,028,513

 

 

$

2.85

 

 

 

7.01

 

 

$

7,005

 

Summary of RSU activity

A summary of the RSU activity during the nine months ended September 30, 2023 is as follows:

 

 

Restricted Stock Units

 

 

Weighted-Average
Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

1,787,152

 

 

$

12.49

 

Granted

 

 

561,973

 

 

$

11.22

 

Vested

 

 

(140

)

 

$

12.50

 

Forfeited

 

 

(10,853

)

 

$

12.54

 

Unvested at September 30, 2023

 

 

2,338,132

 

 

$

12.18

 

 

Summary of Share-based Compensation Expense

Stock-based compensation expense included in the Company’s condensed consolidated statements of operations and comprehensive loss is as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

General and administrative

 

$

2,566

 

 

$

110

 

 

$

6,661

 

 

$

206

 

Research and development

 

 

662

 

 

 

157

 

 

 

1,899

 

 

 

334

 

Total stock-based compensation expense

 

$

3,228

 

 

$

267

 

 

$

8,560

 

 

$

540